EuroEyes awarded “Leading EVO Visian ICL Implanter in Germany 2021”

1st June 2022

EuroEyes awarded “Leading EVO Visian ICL Implanter in Germany 2021”

EuroEyes International Eye Clinic Limited (“EuroEyes” or the “Company”, together with its subsidiaries, the “Group”, HKEX: 1846) a leading global vision correction service provider, announced today that it has achieved another corporate milestone with the “Leading EVO Visian ICL Implanter in Germany 2021” award from STAAR Surgical Company (“STAAR”) for the most Implantable Collamer® Lens (ICL) surgeries performed in Germany.  

 

Committed to helping clients regain clear vision, EuroEyes offers the most appropriate vision correction solutions that has enabled more than 600,000 patients worldwide to see and experience life as it should be, without the aid of glasses.   

Dr. Jørn S. Jørgensen, Founder, Chairman and CEO of EuroEyes, said: “ICL surgery is one of our strategic focuses and one of our specialized surgery types. Since 1998, EuroEyes has been helping patients regain clear vision with ICL implants, and we are one of the first clinics in the world to perform this kind of surgery. Our commitment to bringing the most innovative vision correction solutions to patients is what makes us a global leader in ophthalmology.”

Implantable Collamer® Lens (ICL) is a single-piece foldable phakic intraocular lens (IOL) made of STAAR’s proprietary Collamer material and implanted into the posterior chamber. It is a fast-growing product deployed in refractive procedures for correcting myopia worldwide.

EuroEyes has seen substantial growth in demand for ICL. In 2021, revenue from performing ICL surgeries grew 30.9% year-on-year to HK$89.4 million and accounted for 14.1% of the Group’s total revenue. Within the revenue generated from ICL surgeries during this period, those performed in Germany increased by 37.4% to HK$49.2 million and in China went up by 27.7% to HK$38.3 million.[1]

With widespread of Myopia among China’s population, STAAR’s EVO ICL was able to capture more than 20% of market share in the country in less than 5 years[2], with EuroEyes being one of its key partners who have begun implanting ICL in China since 2012 and is one of the market leaders.

Dr. Jørn S. Jørgensen added: “STAAR has been an innovator in ICL, and that is why they have been one of our trusted partners throughout the years. We are honoured to be recognized again as the ‘Leading EVO Visian ICL Implanter in Germany 2021’. Our shared vision of delivering visual freedom to patients worldwide – especially in China where there have been huge demand – will not only enable more people to see the world better, but also enable us to collectively build a better future.”

Earlier this month, Dr. Jørn S. Jørgensen together with four other EuroEyes doctors received the "Germany's Excellent Doctors 2022" award for refractive surgery from German news magazine STERN in the special issue "Gute Ärzte für mich" (Good Doctors for Me). The list of awardees were selected together with independent research institute Munich Inquire Media GmbH (MINQ), which has been compiling lists of the best doctors and clinics in Germany since 2010.

 

[1] EuroEyes 2021 Annual Results

[2] STAAR Surgical Investor Presentation 2022